IMARA Inc. (IMRA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

116 HUNTINGTON AVENUE BOSTON, MA 02116

Imara Inc. operates as a biopharmaceutical company. The Company develops novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. IMARA serves customers worldwide.

Data as of 2021-01-23
Market Cap244.4 Million Shares Outstanding17.407 Million Avg 30-day Volume164.62 Thousand
P/E Ratio-2.2 Dividend Yield EPS-6.38
Price/Sales Price cash flow ratio Price free cash flow ratio-8.4
Book Value5.44 Price to Tangible Book2.58 Alpha-0.05
Short Interest Ratio % Short Interest to Float R-squared0.197103
BETA3.29794 52-week High/Low62.71 / 12.9 Stddev0.410842
View SEC Filings from IMRA instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 32 35 -8.57% 6 (0.39%) 8 (0.52%) -25.0%
13F shares: 11.227 Million 10.935 Million 2.67% 3.941 Million 4.452 Million -11.48%
% Ownership 64.8033 63.2782 2.41% 22.75 25.7652 -11.7%
New Positions: 2 24 -91.67% 4
Increased Positions 8 4 100.0% 2
Closed Positions 4 6 -33.33% 2 5 -60.0%
Reduced Positions 16 4 300.0% 3 3 0.0%
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IMRA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMRA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

6.3 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

6.3 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BALLAL RAHUL D. CHIEF EXECUTIVE OFFICER

  • Officer
0 2020-12-17 2

GRAY MICHAEL CFO & COO

  • Officer
0 2020-12-11 1

CONNER EDWARD R.

  • Director
0 2020-04-22 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER

2020-12-21 16:47:04 -0500 2020-12-17 M 4,999 d 263,999 direct

BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER

2020-12-21 16:47:04 -0500 2020-12-17 S 4,999 $25.00 d 0 direct yes -3.9693 -8.9629 0.0 1 -9.7738 5

BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER

2020-12-21 16:47:04 -0500 2020-12-17 M 4,999 $3.15 a 4,999 direct -3.9693 -8.9629 0.0 1 -9.7738 5

BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER

2020-12-16 16:15:02 -0500 2020-12-14 M 1 d 268,998 direct

BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER

2020-12-16 16:15:02 -0500 2020-12-14 S 1 $25.00 d 0 direct yes -0.0838 -7.7503 0.0 1 -7.7503 6

BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER

2020-12-16 16:15:02 -0500 2020-12-14 M 1 $3.15 a 1 direct -0.0838 -7.7503 0.0 1 -7.7503 6

GRAY MICHAEL - Officer CFO & COO

2020-12-15 16:26:20 -0500 2020-12-11 M 1,250 $4.92 a 1,250 direct -1.0775 -6.7551 0.0 1 -6.7551 6

GRAY MICHAEL - Officer CFO & COO

2020-12-15 16:26:20 -0500 2020-12-11 M 1,250 d 223,059 direct

GRAY MICHAEL - Officer CFO & COO

2020-12-15 16:26:20 -0500 2020-12-11 S 1,250 $25.00 d 0 direct yes -1.0775 -6.7551 0.0 1 -6.7551 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments